United States Securities And Exchange Commission
Washington, D.C. 20549
FORM 10-QSB
X
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
Transition report pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Commission File Number 0-12728
INTEGRAL VISION, INC.
(Exact name of registrant as specified in its charter)
Michigan | 38-2191935 |
(State or other jurisdiction of incorporation or | (I.R.S. Employer Identification Number) |
organization) | |
49113 Wixom Tech Drive | |
Wixom, Michigan | 48393 |
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (248) 668-9230
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES X NO ____
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ____ NO X
Indicate by check mark whether
the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange
Act).
YES ____ NO X
The number of shares outstanding on each of the issuer's classes of common stock, as of the latest practicable date: As of November 14, 2006:
Common Stock, No Par Value, Stated Value $.20 Per Share 29,491,409
Transitional Small Business Format (check one): YES ____ NO X
INTEGRAL VISION, INC.
FORM 10-QSB Report
September 30, 2006
TABLE OF CONTENTS
PART I. | FINANCIAL INFORMATION | ||
Item 1. | Financial Statements (Unaudited) | 3 | |
Condensed Consolidated Balance Sheets | |||
as of September 30, 2006 (unaudited) and December 31, 2005 | 3-4 | ||
Condensed Consolidated Statements of Operations | |||
(unaudited) for the three months and the nine months ended | |||
September 30, 2006 and 2005 | 5 | ||
Consolidated Statement of Stockholders Equity (unaudited) | 7 | ||
Condensed Consolidated Statements of Cash Flows | |||
(unaudited) for the nine months ended | |||
September 30, 2006 and 2005 | 8 | ||
Notes to Condensed Consolidated Financial Statements (unaudited) | 9 | ||
Item 2. | Managements Discussion and Analysis of | ||
Financial Condition and Results of Operations | 19 | ||
Item 3. | Controls and Procedures | 25 | |
PART II. | OTHER INFORMATION | ||
Item 1. | Legal Proceedings | 26 | |
Item 6. | Exhibits | 26 | |
Signatures | 29 |
2
INTEGRAL VISION, INC. AND SUBSIDIARY
Condensed Consolidated Balance Sheets
|
|
|
||||||
|
|
|
||||||
|
|
|
|
|
||||
|
||||||||
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash | $ | 272 | $ | 2,501 | ||||
Accounts receivable, less allowance of $27,000 ($0 in 2005) | 178 | 77 | ||||||
Inventories - Note A | 359 | 362 | ||||||
Other current assets | 107 | 102 | ||||||
TOTAL CURRENT ASSETS | 916 | 3,042 | ||||||
PROPERTY, PLANT AND EQUIPMENT: | ||||||||
Leasehold Improvements |
-
|
43 | ||||||
Builidng Improvements | 4 | 2 | ||||||
Production and engineering equipment | 202 | 187 | ||||||
Furniture and fixtures | 80 | 80 | ||||||
Vehicles |
-
|
18 | ||||||
Computer equipment | 188 | 166 | ||||||
Marketing demonstration equipment | 161 |
-
|
||||||
635 | 496 | |||||||
Less accumulated depreciation | (351 | ) | (382 | ) | ||||
284 | 114 | |||||||
OTHER ASSETS net of accumulated ammortization of $1,480,000 ($1,436,000 in 2005) | 35 | 71 | ||||||
$ | 1,235 | $ | 3,227 |
See notes to condensed consolidated financial statements.
3
INTEGRAL VISION, INC. AND SUBSIDIARY
Condensed Consolidated Balance Sheets Continued
|
|
|
||||||
|
|
|
||||||
|
|
|
|
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable | $ | 78 | $ | 48 | ||||
Accrued compensation and related costs | 310 | 294 | ||||||
Accrued interest | 8 | 15 | ||||||
Other accrued liabilities | 159 | 108 | ||||||
TOTAL CURRENT LIABILITIES | 555 | 465 | ||||||
Long-term debt | 378 | 378 | ||||||
TOTAL LIABILITIES | 933 | 843 | ||||||
STOCKHOLDERS EQUITY: | ||||||||
Preferred stock, 400,000 shares authorized; none issued |
-
|
-
|
||||||
Common stock, without par value, stated value $.20 | ||||||||
per share; 41,000,000 shares authorized; 29,491,409 shares issued | ||||||||
and outstanding
|
5,898 | 5,898 | ||||||
Additional paid-in capital | 39,264 | 39,126 | ||||||
Accumulated deficit | (44,860 | ) | (42,640 | ) | ||||
Total Stockholders Equity | 302 | 2,384 | ||||||
$ | 1,235 | $ | 3,227 |
See notes to condensed consolidated financial statements.
4
INTEGRAL VISION, INC. AND SUBSIDIARY
Condensed Consolidated Statements of Operations
|
||||||||
|
|
|
||||||
|
||||||||
Revenues: | |
|||||||
Net product sales |
$
|
283 |
$
|
14 | ||||
Net revenue from product development agreements | 70 | - |
||||||
Total net revenues
|
353 | 14 | ||||||
Costs of sales: | ||||||||
Costs of sales for products | 225 | 39 | ||||||
Cost of sales for product development agreements | 69 | - | ||||||
Depreciation and amortization | 4 | 31 |
||||||
Total costs of sales | 298 | 70 |
||||||
Gross margin (loss) | 55 | (56 | ) | |||||
Other costs and expenses: | ||||||||
Marketing | 173 | 142 | ||||||
General and administrative - net | 289 | 372 | ||||||
Engineering and development - net | 254 | 234 | ||||||
Total other costs and expenses | 716 | 748 |
||||||
Operating loss | (661 | ) | (804 | ) | ||||
Other income | 2 | - | ||||||
Interest income | 6 | 31 | ||||||
Interest expense | (8 | ) | (7 | ) | ||||
Net loss |
$
|
(661 | ) |
$
|
(780 | ) | ||
Basic and diluted loss per share: | ||||||||
Net loss |
$
|
(0.02 | ) |
$
|
(0.03 | ) | ||
Weighted average number of shares of common stock and | ||||||||
common stock equivalents, where applicable | 29,491 | 29,466 |
See notes to condensed consolidated financial statements.
5
INTEGRAL VISION, INC. AND SUBSIDIARY
Condensed Consolidated Statements of Operations
|
||||||||
|
|
|
||||||
|
||||||||
Revenues: | |
|||||||
Net product sales |
$
|
588 |
$
|
545 | ||||
Net revenue from product development agreements | 172 |
-
|
||||||
Total net revenues
|
760 | 545 | ||||||
Costs of sales: | ||||||||
Costs of sales for products | 430 | 307 | ||||||
Cost of sales for product development agreements | 165 |
-
|
||||||
Depreciation and amortization | 48 | 101 | ||||||
Total costs of sales | 643 | 408 | ||||||
Gross margin | 117 | 137 | ||||||
Other costs and expenses: | ||||||||
Marketing | 500 | 389 | ||||||
General and administrative - net | 956 | 972 | ||||||
Engineering and development - net | 911 | 686 | ||||||
Total other costs and expenses | 2,367 | 2,047 | ||||||
Operating loss | (2,250 | ) | (1,910 | ) | ||||
Other income - net | 12 | 22 | ||||||
Interest income | 41 | 52 | ||||||
Interest expense | (23 | ) | (135 | ) | ||||
Net loss |
$
|
(2,220 | ) |
$
|
(1,971 | ) | ||
Basic and diluted loss per share: | ||||||||
Net loss |
$
|
(0.08 | ) |
$
|
(0.09 | ) | ||
Weighted average number of shares of common stock and | ||||||||
common stock equivalents, where applicable | 29,491 | 22,860 |
See notes to condensed consolidated financial statements.
6
INTEGRAL VISION, INC. AND SUBSIDIARY
Consolidated Statement of Stockholders' Equity (unaudited)
|
||||||||||||||||
|
|
|||||||||||||||
Shares |
|
|
||||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
Balance at January 1, 2006 | |
$ | |
$ | 39,126 | $ | (42,640 | ) | $ | 2,384 | ||||||
Net loss for the period | (2,220 | ) | (2,220 | ) | ||||||||||||
Share based compensation | 138 | 138 | ||||||||||||||
Balance at September 30, 2006 | |
$ |
|
$ | 39,264 | $ | (44,860 | ) | $ | 302 |
See notes to condensed consolidated financial statements.
7
INTEGRAL VISION, INC. AND SUBSIDIARY
Condensed Consolidated Statements of Cash Flows
|
||||||||
|
|
|
||||||
|
||||||||
|
||||||||
Cash Flows From Operating Activities: | ||||||||
Net loss | $ | (2,220 | ) | $ | (1,971 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation | 32 | 7 | ||||||
Amortization | 44 | 117 | ||||||
Share-based compensation | 138 |
-
|
||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (101 | ) | (63 | ) | ||||
Inventories | (150 | ) | (100 | ) | ||||
Other current assets | (5 | ) | 1 | |||||
Accounts payable and other current liabilities | 90 | (79 | ) | |||||
Net Cash Used In Operating Activities | (2,172 | ) | (2,088 | ) | ||||
Cash Flows From Investing Activities: | ||||||||
Purchase of property and equipment | (49 | ) | (32 | ) | ||||
Additional patent expenditures | (8 | ) | (27 | ) | ||||
Net Cash Used In Investing Activities | (57 | ) | (59 | ) | ||||
Cash Flows From Financing Activities: | ||||||||
Issuance of preferred stock | - | 6,235 | ||||||
Proceeds from exercise of warrants | - | 1,865 | ||||||
Proceeds from sale of Class 2 Notes | - | 435 | ||||||
Repayments of principal and interest on Class 1 Notes | - | (1,289 | ) | |||||
Repayments of principal and interest on Class 2 Notes | - | (1,823 | ) | |||||
Repayments of interest on Class 3 Notes | - | (106 | ) | |||||
Repayments on short term notes | - | (111 | ) | |||||
Proceeds from exercise of stock options | - | 5 | ||||||
Net Cash Provided By Financing Activities | - | 5,211 | ||||||
Increase (Decrease) in Cash | (2,229 | ) | 3,064 | |||||
Cash at Beginning of Period | 2,501 | 191 | ||||||
Cash at End of Period | $ | 272 | $ | 3,255 | ||||
Supplemental cash flows disclosure: | ||||||||
Interest paid | $ | 30 | $ | 457 | ||||
Reclassification of inventory to equipment | $ | 153 | $ |
-
|
See notes to condensed consolidated financial statements.
8
Integral Vision, Inc. and Subsidiary
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note A - Significant Accounting Policies
The condensed consolidated financial statements in this report have been prepared by Integral Vision, Inc. without audit, pursuant to the rules of the Securities and Exchange Commission for quarterly reports on Form 10-QSB and do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America for annual consolidated financial statements. These statements should be read in conjunction with the consolidated financial statements and notes for the year ended December 31, 2005, included in the Companys form 10-KA filed with the Securities and Exchange Commission on March 31, 2006 and the Companys forms 10-QSB filed with the Securities and Exchange Commission on May 15, 2006 and August 14, 2006.
In the opinion of management, information included in this report reflects all adjustments, consisting only of normal, recurring adjustments, necessary for fair presentation of results for these interim periods.
The results of operations for the three month and the nine month periods ended September 30, 2006, are not necessarily indicative of the results to be expected for the entire year ending December 31, 2006.
Nature of Business
During the period ended March 31, 2006, the Company began activity associated with a product development agreement where the Company is compensated for a portion of its development costs for a certain best efforts product development. The Company may not be able to find future opportunities like this, but remains open to such development agreements where they facilitate the Companys strategic goals.
Principles of Consolidation
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Estimates also affect
9
the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Inventories
Inventories are stated at the lower of first-in, first-out (FIFO) cost or market. Cost is computed using currently adjusted standards which approximates actual costs on a FIFO basis. The Company assesses the recoverability of all inventory to determine whether adjustments for impairment are required. At September 30, 2006 and December 31, 2005, inventories consisted of the following amounts (net of obsolescence reserves of $97,000 at September 30, 2006 and at December 31, 2005):
|
|
|
||||
|
|
|
||||
|
||||||
Raw materials | $ | 221
|
$ | 154 | ||
Work in process | 138
|
55 | ||||
Finished goods | -
|
153 | ||||
$ | 359
|
$ | 362 |
Deferred Revenues
Revenue Recognition
The Company accounts for certain product sales of its flat panel display inspection systems as multiple-element arrangements. If specific customer acceptance requirements are met, the Company recognizes revenue for a portion of the total contract price due and billable upon shipment, with the remainder recognized when it becomes due (generally upon acceptance). The Company recognizes all other product sales with customer acceptance provisions upon final customer acceptance. The Company recognizes revenue from the sale of spare parts upon shipment. Revenue from service contracts is recognized over the life of the contract. Revenue is reported net of sales commissions.
Revenue is also derived through business agreements for product development. The Company conducts specified product development projects related to one of its principal technology specializations for an agreed-upon fee. Typically the agreements require a best efforts with no specified performance criteria. Revenue from product development agreements, where there are no specific performance terms, are recognized in amounts equal to the amounts expended on the programs. Generally, the agreed-upon fees for product development agreements contemplate reimbursing the Company, after its agreed-upon cost share, if any, for costs considered
10
associated with project activities including expenses for direct product development and research, operating, general and administrative expenses and depreciation. Accordingly, expenses related to product development agreements are recorded as cost of revenues from product development agreements.
Allocations of General and Administrative Costs and Engineering Costs
The following is a summary of the allocations made for the three months and nine months ended September 30:
|
|
|
||||||||||||
|
|
|
|
|||||||||||
|
(in thousands) | |||||||||||||
Gross G&A Expense | $ | 304 | $ |
372
|
$ | 986 | $ | 972
|
||||||
Less allocation to cost of sales from | ||||||||||||||
product development agreements | (15 | ) |
-
|
(30 | ) | -
|
||||||||
Remaining G&A Expense | $ | 289 | $ |
372
|
$ | 956 | $ | 972
|
||||||
|
|
|
|
|||||||||||
|
|
|||||||||||||
Gross Engineering and Development | ||||||||||||||
Expense | $ | 305 | $ |
234
|
$ | 1,031 | $ | 686
|
||||||
Less allocation to cost of sales from | ||||||||||||||
product development agreements | (51 | ) |
-
|
(120 | ) | -
|
||||||||
Remaining Engineering and | ||||||||||||||
Development Expense | $ | 254 | $ | 234
|
$ | 911 | $ | 686
|
Reclassifications
Recently Issued Accounting Standards
11
In addition, SAB 108 provides transition guidance for correcting errors existing in prior years. If prior-year errors that had been previously considered immaterial (based on the appropriate use of the registrants prior approach) now are considered material based on the approach of this SAB, the registrant need not restate prior period financial statements. SAB 108 is effective for Integral Visions annual financial statements covering our fiscal year ending December 31, 2006, with earlier application encouraged for any interim period of our current fiscal year and filed after September 13, 2006.
While the Company is considering the effects of implementing its provisions, management does not presently bellieve SAB 108 will have a material impact on Integral Visions financial position or results of operations.
On September 15, 2006, the FASB issued SFAS No. 157, Fair Value Measurements, which provides for enhanced guidance for using fair value to measure assets and liabilities. SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. SFAS No. 157 is applicable under other accounting pronouncements that either require or permit fair value measurements and does not require any new fair value measurements. SFAS No. 157 is effective for the Companys financial statements issued for fiscal periods beginning January 1, 2008. Integral Vision is in the process of analyzing the implications of SFAS No. 157.
Note B Loss per Share
The following table sets forth the computation of basic and diluted loss per share:
|
|
|
||||||||||||||
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||
|
||||||||||||||||
|
||||||||||||||||
Numerator for basic and diluted loss per share loss | ||||||||||||||||
available to common stockholders | ||||||||||||||||
Net loss |
$
|
(661 | ) |
$
|
(780 | ) |
$
|
(2,220 | ) |
$
|
(1,971 | ) | ||||
*there was no effect of dilutive securities see below | ||||||||||||||||
Denominator for basic and diluted loss per | ||||||||||||||||
share weighted average shares | 29,491 | 29,466 | 29,491 | 22,860 | ||||||||||||
*there was no effect of dilutive securities see below | ||||||||||||||||
BASIC AND DILUTED LOSS PER SHARE: |
$
|
(0.02 | ) |
$
|
(0.03 | ) |
$
|
(0.08 | ) |
$
|
(0.09 | ) |
Warrants and options outstanding were not included in the computation of diluted earnings per share because the inclusion of these instruments would have an antidilutive effect. For additional disclosures regarding stock options see Note D and H.
Note C Income Taxes
The Company establishes valuation allowances in accordance with the provisions of FASB Statement No. 109, Accounting for Income Taxes. The Company continually reviews realizability of deferred tax assets
12
and recognizes these benefits only as reassessment indicates that it is more likely than not that the benefits will be realized.
Note D - Stock Options
The Company adopted SFAS No. 123R, under the modified prospective transition method on January 1, 2006. SFAS No. 123R requires companies to measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value. Share-based compensation recognized under the modified-prospective transition method of SFAS No. 123R includes share-based compensation based on the grant-date fair value determined in accordance with the original provisions of SFAS No. 123, Accounting for Stock-Based Compensation, for all share-based payments granted prior to and not yet vested as of January 1, 2006 and share-based compensation based on the grant-date fair-value determined in accordance with SFAS No. 123R for all share-based payments granted after January 1, 2006. SFAS No. 123R eliminates the ability to account for the award of these instruments under the intrinsic value method proscribed by Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and allowed under the original provisions of SFAS No. 123. Prior to the adoption of SFAS No. 123R, the Company accounted for our stock option plans using the intrinsic value method in accordance with the provisions of APB Opinion No. 25 and related interpretations.
Primarily as a result of adopting SFAS No. 123R, the Company recognized $57,964 and $137,946 in share-based compensation expense for the three and nine months ended September 30, 2006 respectively. The impact of this share-based compensation expense on the Companys basic and diluted earnings per share was $0.00 per share for the three months and the nine months ended September 30, 2006. No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for all net deferred tax assets. The fair value of our stock options was estimated using the Black-Scholes option pricing model with the following weighted-average assumptions for the three and nine months ended September 30, 2006:
Three Months Ended | Nine Months Ended | |||||
September 30, 2006 | September 30, 2006 | |||||
|
||||||
Expected Life (in years) | 6.0 | 6.4 | ||||
Expected volatility | 83.23 | % | 101.55 | % | ||
Risk-free interest rate | 4.96 | % | 3.68 | % | ||
Expected dividend yield | 0 | % | 0 | % | ||
Expected forfiture rate | 0 | % | 0 | % |
Valuation and Amortization Method. We estimate the fair value of share-based awards granted using the Black-Scholes option valuation model. We amortize the fair value of all awards on a straight-line basis over the requisite service periods, which are generally the vesting periods.
Expected Life. The expected life of all awards granted represents the period of time that they are expected to be outstanding. We determine the expected life using historical and other information available at the time of grant.
Expected Volatility. Using the Black-Scholes option valuation model, we estimate the volatility of our common stock at the date of grant based on the historical volatility of our common stock.
Risk-Free Interest Rate. We base the risk-free interest rate used in the Black-Scholes option valuation model on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.
13
Expected Forfeitures. We use historical data to extimate pre-vesting option forfitures. We record stock-based compensation only for those awards that are expected to vest.
The following table summarizes share-based compensation expense related to share-based awards under SFAS No. 123R for the three and nine months ended September 30, 2006, which is recorded in the statement of operations in the following catagories:
|
|
|
||||
|
|
|
||||
|
||||||
Marketing expense | $ |
12 | $ |
27 | ||
Engineering and Development Expense | 32 | 76 | ||||
General and Administrative Expense | |
14 | |
35 | ||
Total share based compensation expense | $ |
58 | $ |
138 |
As of September 30, 2006, the Company has $144,910 of unrecognized expense related to un-vested share-based compensation.
For periods presented prior to the adoption of SFAS No. 123R, pro forma information regarding net income and earnings per share as required by SFAS No. 123R has been determined as if we had accounted for our employee stock options under the original provisions of SFAS No. 123. The fair value of these options was estimated using the Black-Scholes option pricing model. For purposes of pro forma disclosure, the estimated fair value of the options is amortized to expense over the options vesting period. The fair value of each option grant was estimated with the following weighted-average assumptions for the three and nine months ended September 30, 2005
Three Months Ended | Nine Months Ended | |||||
September 30, 2005 | September 30, 2005 | |||||
|
||||||
Expected Life (in years) | 7.0 | 7.0 | ||||
Expected volatility | 125.6 | % | 125.6 | % | ||
Risk-free interest rate | 2.00 | % | 2.00 | % | ||
Expected dividend yield | 0 | % | 0 | % | ||
Expected forfiture rate | 0 | % | 0 | % |
The following table presents the pro forma net loss and basic and diluted loss per common share, had the Company elected to recognize compensation cost based on the fair value at the grant dates for stock options awards, consistent with the methods prescribed by SFAS 123, as amended by SFAS 148:
14
|
|
|
||||||
|
|
|
||||||
|
||||||||
Net loss: | ||||||||
Net loss, as reported | $ | (780 | ) |
$
|
(1,971 | ) | ||
Deduct: Total stock-based compensation | ||||||||
expense determined under fair value method | ||||||||
for all awards, net of related tax effects | (51 | ) | (198 | ) | ||||
Pro forma net loss | $ | (831 | ) |
$
|
(2,169 | ) | ||
Basic and diluted earnings per share: | ||||||||
Basic and diluted - as reported | $ | (0.03 | ) |
$
|
(0.09 | ) | ||
Basic and diluted - pro forma | $ | (0.03 | ) |
$
|
(0.09 | ) |
A summary of option activity under all plans for the nine months ended September 30, follows:
|
||||
|
|
|
||
|
||||
|
||||
Outstanding at December 31, 2005 | 1,114 |
$
|
0.97 | |
Granted | 210 | 1.50 | ||
Exercised | 0 | 0.00 | ||
Expired | (15 | ) | 6.25 | |
Outstanding at September 30, 2006 | ||||
($.10 to $5.63 per share) | 1,309 | 1.00 | ||
Exercisable ($.10 to $5.63 per share) | 1,099 |
$
|
0.90 |
Additional information regarding the range of exercise prices and weighted average remaining life of options outstanding at September 30, 2006 follows:
Weighted | ||||
|
Number | Average | Number | |
|
Outstanding |
|
Exercisable | |
|
||||
$.10 to $1.40 | 938 | 5.9 | 938 | |
$1.50 to $ 5.63 | 371 | 8.1 | 161 | |
$.10 to 5.63 | 1,309 | 6.5 | 1,099 |
As of September 30, 2006, the Company had $378,000 in outstanding Class 3 Notes payable that are convertible into the Companys common stock at $1.00 per share. The notes are due April 1, 2008 and interest is paid semi-annually at 8%.
A summary of the outstanding warrants, options, and shares available upon the conversion of debt at September 30, 2006 is as follows:
15
|
||||||||
Warrants | $ | 1.60 |
3,500 | 3.53 | 3,500 | |||
Class 2 Note (1) | $ | 1.00 |
321 | 2.48 | 321 | |||
Class 3 Notes | $ | 1.00 |
378 | 1.50 | 378 | |||
1995 Employee Stock Option Plan | $ | 0.99 |
360 | 3.96 | 360 | |||
1999 Employee Stock Option Plan | $ | 0.27 |
355 | 5.50 | 355 | |||
2004 Employee Stock Option Plan | $ | 1.44 |
594 | 8.67 | 384 | |||
$ | 1.38 |
5,508 | 4.04 | 5,298 |
(1) The table has been corrected since the Companys 10-QSB dated as of June 30, 2006 to reflect warrants issued thru April 12 of 2005. These warrants do not have a dilutive effect on earnings.
Note E Contingencies and Litigation
Product Warranties
The following table illustrates the changes in our warranty reserves for the nine months ended September 30, 2006 and 2005:
|
|
|||||||
|
|
|||||||
|
||||||||
Balance as of December 31 |
$
|
80 | $ | 155 | ||||
Charges/credits to expense | - | 26 | ||||||
Utilization/payment | (3 | ) | - | |||||
Balance as of March 31 |
$
|
77 | $ | 181 | ||||
Charges/credits to expense | 5 | (35 | ) | |||||
Utilization/payment | (7 | ) | (3 | ) | ||||
Balance as of June 30 |
$
|
75 | $ | 143 | ||||
Charges/credits to expense | 12 | - | ||||||
Utilization/payment | (7 | ) | - | |||||
Balance as of September 30 |
$
|
80 | $ | 143 |
Legal Matters
16
NOTE F - Going Concern
In order to help fund current operations, management has made arrangements to sell up to $500,000 of Class 2 Notes under the terms of the Companys existing Note and Warrant Purchase Agreement as amended. The Class 2 Notes are working capital notes and are secured by accounts receivable, inventory, and intellectual property. The terms of these notes and their potential dilution are described more fully in Note H - Subsequent Events. Management believes that other sources are available if additional funding is needed.
The Company believes that with the sale of the notes, existing backlog and anticipated orders based on quote activity and technical and other discussions with customers, and additional funding if needed, it should have sufficient resources to fund current operations through the fourth quarter of 2007. However, the Companys continuation as a going concern is ultimately dependent upon achieving the necessary sales to attain profitability. The Company has several large companies as customers. These companies are working with new microdisplay technologies. Integral Visions success will be partly dependant on these large companies getting their emerging display technologies into high volume production and placing sales orders with the Company for inspection products to support that production.
The condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
Note G Other Matters
Note H Subsequent Events
The Compensation Committee of the Board of Directors modified the terms of the Companys May 16, 2006 option award program. The modification which is effective October 24, 2006 changed the exercise/strike price from $1.50 to $.60 per share and changed the vesting period from one year to two years.
The financial statement impact of the modifications, which was determined in accordance with SFAS 123R increased the award program cost by $18,792. This amount added to the unrecognized cost of $144,910 for the original option award program is $163,702 and will be recognized ratably as compensation cost over the vesting period remaining at the modification date plus one year.
Management believes that the option award program modifications were necessary to provide the Company with an effective means of retaining and motivating officers and key employees and to provide them with incentives to enhance the growth and profitability of the Company.
17
Management has made arrangements to sell up to $500,000 of Class 2 Notes under the terms of the Companys existing Note and Warrant Purchase Agreement as amended. The Class 2 Notes are working capital notes and are secured by accounts receivable, inventory, and intellectual property. The purchasers of Class 2 Notes receive 10% interest and the option to receive either warrants for the purchase of the Companys stock when the Note is repaid or an additional 2% interest. Class 2 Warrants entitle the holder to purchase one share of Common Stock for each $1 in value of the Class 2 Note multiplied by a fraction, the numerator of which is the number of days such Class 2 note is outstanding and the denominator of which is 365, at a specific price which shall be approximately 150% of the recent fair value of the Companys Common Stock as agreed by the parties as of the date of issuance of the corresponding Class 2 Note or such other price as the Board of Directors shall determine is appropriate based on the circumstances at the time. The Board of Directors has approved a $1.60 strike price for the warrants. The Notes will expire May 31, 2007. Management anticipates selling these notes during the fourth quarter of 2006 and the first first quarter of 2007.
18
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
Overview
Integral Visions customers and potential customers are primarily large companies with significant investment in the manufacture of displays. These companies are working with new microdisplay technologies. Integral Visions success will be substantially dependant on these large companies getting their emerging display technologies into high volume production.
Nearly all of the Companys sales originate in the United States, Asia, or Europe. The Company's products are generally sold as capital goods. Depending on the application, display inspection systems have an indefinite life and are more likely to require replacement due to possible technological obsolescence than from physical wear.
During the period ended March 31, 2006 the Company began activity associated with a product development agreement with Energy Conversion Devices (ECD) where the Company is compensated for a portion of its costs for the development of online inspection for a continuous web of display material. This best efforts subcontract with ECD proceeds from a contract from the United States Display Consortium. The Company may not be able to find future opportunities like this, but remains open to such development agreements where they facilitate the Companys strategic goals.
19
ChromaSee Integral Visions ChromaSee product, which was introduced in 2003, provides luminance, color matching and defect inspections for FPD displays. Defect detection includes functional (e.g. failed pixels, icons) and cosmetic (e.g. scratches) defects. ChromaSee integrates with production equipment to allow inline or offline testing. A configuration interface (Task Sequencer) uses a familiar Tree View representation of the inspection sequence flow. For deployment into production, the operators interface provides essential views of results, images and statistics for production floor personnel.
Lifetime Tester Integral Visions Lifetime Tester product, which was introduced in 2003, evaluates changes in display luminance, color and other performance characteristics over time. The Lifetime Tester facilitates the process of comparing different display manufacturing processes and formulas by evaluating large numbers of samples side by side to determine their life characteristics. This allows design and process engineers to efficiently evaluate the effectiveness of proposed design and process changes off line prior to implementation.
IVSee Integral Visions IVSee, introduced in 2005, provides FPD inspection for applications which still require manual handling. IVSee is designed for the detection of functional and cosmetic defects in LCOS, OLED, MEMS, 3LCD/HTPS, LCD and other emerging display technologies. IVSee is configured to be integrated into existing manual inspection stations allowing them to receive the benefits of computer aided optical inspection without the need to modify the manufacturing process to automate handling of the display. The operators interface provides essential views of results, images, and statistics for production floor personnel.
Results of Operations
Three Months Ended September 30, 2006 Compared with Three Months Ended September 30, 2005
Net revenues increased $339,000 to $353,000 in the third quarter of 2006 from $14,000 in the third quarter of 2005. The increase in net revenue was primarily attributable to an increase to $280,000 in revenue from sales of the Companys flat panel display inspection products in the third quarter of 2006 compared to $13,000 of sales from that product line in the comparable 2005 period. Additionally, the third quarter of 2006 included $70,000 of revenue from product development agreements; there were no such revenues in 2005.
Costs of sales increased $228,000 (326%) to $298,000 (84.4% of sales) in the third quarter of 2006 compared to $70,000 (5000.0% of sales) in the third quarter of 2005. This was primarily due to an increase in material costs as a result of the higher sales of flat panel display inspection products in the 2006 period. Additionally, the third quarter of 2006 included $69,000 in costs related to product development agreements while there were no such costs in 2005.
20
Marketing costs increased $31,000 (21.8%) to $173,000 in the third quarter of 2006 compared to $142,000 in the third quarter of 2005. This was attributable to increased staffing and related costs and the amortization of share-based compensation as required by SFAS 123R.
General and administrative costs decreased $83,000 (22.3%) to $289,000 in the third quarter of 2006 compared to $372,000 in the third quarter of 2005. $15,000 of general and administrative costs were allocated to costs of sales for product development agreements. (For more information on the allocation of certain general and administrative costs to cost of goods sold see Note A to the Condensed Consolidated Financial Statements.) Without this allocation, general and administrative costs would have decreased by $68,000 (18.3%) from the third quarter of 2005 to $304,000. This is attributable to a reduction in legal and consulting fees partially offset by the amortization of share-based compensation as required by SFAS 123R.
Engineering and development expenditures increased $20,000 (8.5%) to $254,000 in the third quarter of 2006 compared to $234,000 in the third quarter of 2005. $51,000 of engineering costs were allocated to costs of sales for product development agreements. (For more information on the allocation of certain engineering costs to cost of goods sold see Note A to the Condensed Consolidated Financial Statements.) Without this allocation, engineering costs would have increased by $71,000 (30.3%) over the third quarter of 2005 to $305,000. This is primarily attributable to additional staffing and related costs, increases in outside services, and the amortization of share-based compensation as required by SFAS 123R.
Interest income decreased $25,000 to $6,000 in 2006 from $31,000 in 2005. The decrease was primarily attributable to the use of cash reserves for daily operations.
Interest expense remained essentially the same at $8,000 in the third quarter of 2006 compared to $7,000 in the third quarter of 2005.
Nine months Ended September 30, 2006 Compared with Nine months Ended September 30, 2005
Net revenues increased $215,000 (39.4%) to $760,000 in 2006 from $545,000 in 2005. The increase in net revenue was primarily attributable to an increase of $172,000 in revenue from product development agreements; there were no such revenues in 2005. Additionally sales of the Companys flat panel display inspection products increased $43,000 in the first nine months of 2006 compared to sales from that product line in the comparable 2005 period.
Costs of sales increased $235,000 (57.6%) to $643,000 (84.6% of sales) in 2006 compared to $408,000 (74.9% of sales) in 2005. This was primarily due to an increase of $165,000 in costs related to product development agreements. Costs of sales for product development agreements are recorded in amounts equal to the revenue recognized and therefore do not contribute significantly to gross margin. See Note A to the Condensed Consolidated Financial Statements Revenue Recognition and Note A to the Condensed Consolidated Financial Statements Allocations of General and Adminstrative Costs and Engineering Costs for further discussion of product development agreements.
Marketing costs increased $111,000 (28.5%) to $500,000 in 2006 compared to $389,000 in 2005. This is primarily attributable to increased staffing and related costs, the amortization of share-based compensation as required by SFAS 123R, and increased shipping and import/export fees associate with placing demonstration equipment on customers sites in Asia.
21
General and administrative costs decreased $16,000 (1.6%) to $956,000 in 2006 compared to $972,000 in 2005. $30,000 of general and administrative costs were allocated to costs of sales for product development agreements. (For more information on the allocation of certain general and administrative costs to cost of goods sold see Note A to the Condensed Consolidated Financial Statements.) Without this allocation, general and administrative costs would have increased slightly by $14,000 (1.4%) over 2005 to $986,000.
Engineering and development expenditures increased $225,000 (32.8%) to $911,000 in 2006 compared to $686,000 in 2005. $120,000 of engineering costs were allocated to costs of sales for product development agreements. (For more information on the allocation of certain engineering costs to cost of goods sold see Note A to the Condensed Consolidated Financial Statements.) Without this allocation, engineering costs would have increased by $345,000 (50.3%) over 2005 to $1,031,000. This is primarily attributable to increases for additional staffing and related costs, outside services, and the amortization of share-based compensation as required by SFAS 123R.
Interest income decreased $11,000 (21.1%) to $41,000 in 2006 from $52,000 in 2005. The decrease was primarily attributable to the use of cash reserves for daily operations.
Interest expense decreased $112,000 to $23,000 in 2006 compared to $135,000 in 2005. The decrease is primarily attributable to the repayment of Class 1, Class 2, and Class 3 Notes and other debt in the second quarter of 2005.
Liquidity and Capital Resources
Operating activities for the nine months ended September 30, 2006 used cash of approximately $2,172,000 primarily due to the Companys loss from operations of $2,220,000.
The Companys investing activities included the purchase of approximately $49,000 of equipment and $8,000 for patents in the nine months ended September 30, 2006. Additionally, $153,000 of consignment and demonstration equipment was reclassified from inventory to Marketing Demonstration Equipment as capital goods to more accurately reflect how it is being used. Management has made arrangements to sell up to $500,000 of Class 2 Notes under the terms of the Companys existing Note and Warrant Purchase Agreement as amended. The Class 2 Notes are working capital notes and are secured by accounts receivable, inventory, and intellectual property. The terms of these notes and the potential dilution are described more fully in Note H - Subsequent Events. Management believes that sources are available if additional funding is needed. This could result in additional shareholder dilution depending on the final terms of the agreement.
The Company believes that with the sale of the notes, existing backlog and anticipated orders based on quote activity and technical and other discussions with customers, and additional funding if needed, it should have sufficient resources to fund current operations through the fourth quarter of 2007. However, the Companys continuation as a going concern is ultimately dependent upon achieving the necessary sales to attain profitability. The Company has several large companies as customers. These companies are working with new microdisplay technologies. Integral Visions success will be partly dependant on these large companies getting their emerging display technologies into high volume production and placing sales orders with the Company for inspection products to support that production.
The Company also has recorded a potential liability estimated at $220,000 to a certain regulatory agency as of September 30, 2006.
22
Managements Discussion of Critical Accounting Policies
The Companys condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires Management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The accounting policies discussed below are considered by management to be the most important to an understanding of our financial statements, because their application places the most significant demands on management's judgment and estimates about the effect of matters that are inherently uncertain. Our assumptions and estimates were based on the facts and circumstances known at September 30, 2006, future events rarely develop exactly as forecast, and the best estimates routinely require adjustment. These policies are also described in Note A to the Notes to Condensed Consolidated Financial Statements included in this Quarterly Form 10-QSB.
Revenue Recognition
The Company recognizes revenue in accordance with SOP 97-2, Software Revenue Recognition, Staff Accounting Bulletin No. 101 (SAB 101) and Staff Accounting Bulletin No. 104 (SAB 104), Revenue Recognition in Financial Statements. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectibility is reasonably assured.
The Company accounts for certain product sales of its flat panel display inspection systems as multiple-element arrangements. If specific customer acceptance requirements are met, the Company recognizes revenue for a portion of the total contract price due and billable upon shipment, with the remainder recognized when it becomes due (generally upon acceptance). The Company recognizes all other product sales with customer acceptance provisions upon final customer acceptance. The Company recognizes revenue from the sale of spare parts upon shipment. Revenue from service contracts is recognized over the term of the contract. Revenue is reported net of sales commissions.
Revenue is also derived through business agreements for product development. The Company conducts specified product development projects related to one of its principal technology specializations for an agreed-upon fee. Typically the agreements require a best efforts with no specified performance criteria. Revenue from product development agreements, where there are no specific performance terms, are recognized in amounts equal to the amounts expended on the programs. Generally, the agreed-upon fees for product development agreements contemplate reimbursing the Company, after its agreed-upon cost share, if any, for costs considered associated with project activities including expenses for direct product development and research, operating, general and administrative expenses and depreciation. Accordingly, expenses related to product development agreements are recorded as cost of revenues from product development agreements.
Inventories
Inventories are stated at the lower of standard cost, which approximates actual cost determined on a first-in, first-out basis, or market. Inventories are recorded net of allowances for unsalable or obsolete raw materials, work-in-process and finished goods. We evaluate on a quarterly basis the status of our inventory to ensure the amount recorded in our financial statements reflects the lower of our cost or the value we expect to receive when we sell the inventory. This estimate is based on several factors, including the condition and salability of our inventory and the forecasted demand for the particular products incorporating these components. Based on current backlog and expected orders, we forecast the upcoming usage of current stock. We record reserves for obsolete and slow-moving parts
23
ranging from 0% for active parts with sufficient forecasted demand up to 100% for excess parts with insufficient demand or obsolete parts. Amounts in work-in-process and finished goods inventory typically relate to firm orders and, therefore, are not subject to obsolescence risk. A review of sales consignment and demonstration inventory revealed that customers typically are using the equipment to confirm its applicability to their situation and then special ordering equipment configured for their specific needs. As such, $153,000 of consignment and demonstration equipment inventory was reclassified to Marketing Demonstration Equipment as capital goods to more accurately reflect how it is being used and is being ammortized over five (5) years.
Impairment of Long-lived Assets
The Company reviews its long-lived assets, including property, equipment and intangibles, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition are less than the carrying amount of the asset.
Share Based Compensation
The Company adopted SFAS No. 123R, under the modified prospective transition method on January 1, 2006. Prior to the adoption of SFAS No. 123R, the Company accounted for our stock option plans using the intrinsic value method in accordance with the provisions of APB Opinion No. 25 and related interpretations. The Company continues to use the Black-Scholes option valuation model to dertermine fair value. For more discussion regarding the Black-Scholes model and the assumptions used by the Company, see Note D to the interim condensed consolidated Financial Statements. Primarily as a result of adopting SFAS No. 123R, the Company recognized $57,964 and $137,946 in share-based compensation expense for the three and nine months ended September 30, 2006 respectively. As of September 30, 2006, the Company has $144,910 of unrecognized expense related to un-vested share-based compensation.
The Compensation Committee of the Board of Directors modified the terms of the Companys May 16, 2006 option award program. The modification which is effective October 23, 2006 changed the exercise/strike price from $1.50 to $.60 and changed the vesting period from one year to two years.
The financial impact of the modifications, which was determined in accordance with SFAS 123R increased the award program cost by $18,792. This amount added to the unrecognized cost of $144,910 for the original option award program is $163,702 and will be recognized ratably as compensation cost over the vesting period remaining at the modification date plus one year.
Management believes that the option award program modifications were necessary to provide the Company with an effective means of retaining and motivating officers and key employees and to provide them with incentives to enhance the growth and profitability of the Company.
Contingencies and Litigation
The Company makes an assessment of the probability of an adverse judgement resulting from current and threatened litigation. The Company accrues the cost of an adverse judgement if in Managements estimation, an adverse settlement is probable and Management can reasonably estimate the ultimate cost of such litigation. The Company has made an accrual for settlement of a complaint filed regarding product shipped to a customer in 2001 which does not have a material effect on the Companys financial statements. The complaint relates to a previous product line and is not associated with the Companys current business of display inspection
24
Item 3. Controls and Procedures
a) |
Evaluation of disclosure controls and procedures |
|
Our chief executive officer and chief financial officer have each reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Securities Exchange Act of 1934 Rules 13a-15(e) and 15(d)-15(e)) as of the end of the period covered by this quarterly report. Based on that evaluation, our chief executive officer and chief financial officer have each concluded that our current disclosure controls and procedures are effective to ensure that information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported, in each case, within the time period specified by the SECs rules and regulations. |
||
b) |
Changes in internal controls |
|
There have not been any significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation. There were no significant deficiencies or material weakness, and therefore no corrective actions were taken. |
||
25
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in litigation regarding product shipped to a customer in 2001. The litigation relates to a previous product line and is not associated with the Companys current business of display inspection. Management has negotiated a settlement and made an accrual for the settlement amount which does not have a material effect on the Companys financial statements.
Item 6. Exhibits
Exhibit Number |
Description
of Document |
|
3.1 |
Articles of Incorporation, as amended (filed as Exhibit 3.1 to the registrant's Form 10-K for the year ended December 31, 1995, SEC file 0-12728, and incorporated herein by reference). |
|
3.2 |
Bylaws of the Registrant, as amended (filed as Exhibit 3.2 to the registrant's Form 10-K for the year ended December 31, 1994, SEC file 0-12728, and incorporated herein by reference). |
|
4.1 |
Note and Warrant Purchase Agreement (filed as Exhibit 4.1 to the registrants Form 8-K dated July 15, 1997, SEC file 0-12728, and incorporated herein by reference). |
|
4.3 |
Form of Integral Vision, Inc. Common Stock Purchase Warrant Certificate (filed as Exhibit 4.3 to registrants Form 8-K dated July 15, 1997, SEC file 0-12728, and incorporated herein by reference). |
|
4.4 |
Note and Warrant Purchase Agreement dated March 29, 2001 including Form of Integral Vision, Inc. 15% Senior Subordinated Secured Note and Integral Vision, Inc. Common Stock Purchase Warrant Certificate (filed as Exhibit 4.4 to registrants Form 10-K for the year ended December 31, 2000, SEC file 0-12728, and incorporated herein by reference). |
|
4.5 |
Form of amended Note and Warrant Purchase Agreement including Form of Integral Vision, Inc. 10% Secured Note and Integral Vision, Inc. Common Stock Purchase Warrant Certificate (filed as Exhibit 4.5 to registrants Form 10-Q for the quarter ended June 30, 2001, SEC file 0-12728, and incorporated herein by reference). |
|
26
4.6 |
Form of Second Amended Note and Warrant Purchase Agreement including Form of Integral Vision, Inc. Class 2 Note and Integral Vision, Inc. Class 2 Common Stock Purchase Warrant Certificate (filed as Exhibit 4.6 to registrants Form 10-Q for the quarter ended March 31, 2002, SEC file 0-12728, and incorporated herein by reference). |
|
4.7 |
Consent to Modifications dated March 17, 2003 modifying the terms of the Second Amended Note and Warrant Purchase Agreement (filed as Exhibit 4.7 to registrants Form 10-K for the year ended December 31, 2002, SEC file 0-12728, and incorporated herein by reference). |
|
4.8 |
Form of Fourth Amended Note and Warrant Purchase Agreement including Form of Integral Vision, Inc. Class 3 Note (filed as Exhibit 4.8 to registrants Form 10-K for the year ended December 31, 2003, SEC file 0-12728, and incorporated herein by reference). |
|
4.9 |
Consent to Modifications dated November 14, 2006 modifying the terms of the Fourth Amended Note and Warrant Purchase Agreement including Form of Integral Vision, Inc. Class 2 Warrant. |
|
10.1 |
Incentive Stock Option Plan of the Registrant as amended (filed as Exhibit 10.4 to the registrant's Form S-1 Registration Statement effective July 2, 1985, SEC File 2-98085, and incorporated herein by reference). |
|
10.2 |
Second Incentive Stock Option Plan (filed as Exhibit 10.2 to the registrant's Form 10-K for the year ended December 31, 1992, SEC File 0-12728, and incorporated herein by reference). |
|
10.3 |
Non-qualified Stock Option Plan (filed as Exhibit 10.3 to the registrant's Form 10-K for the year ended December 31, 1992, SEC File 0-12728, and incorporated herein by reference). |
|
10.4 |
Amendment to Integral Vision, Inc. Incentive Stock Option Plan dated May 10, 1993 (filed as Exhibit 10.3 to the registrant's Form 10-K for the year ended December 31, 1993, SEC File 0- 12728, and incorporated herein by reference). |
|
10.5 |
Integral Vision, Inc. Employee Stock Option Plan (filed as Exhibit 10.5 to the registrant's Form 10-Q for the quarter ended September 30, 1995, SEC file 0-12728, and incorporated herein by reference). |
|
10.6 |
Form of Confidentiality and Non-Compete Agreement Between the Registrant and its Employees (filed as Exhibit 10.4 to the registrant's Form 10-K for the year ended December 31, 1992, SEC File 0-12728, and incorporated herein by reference). |
|
10.7 |
Integral Vision, Inc. 1999 Employee Stock Option Plan (filed as Exhibit 10.5 to the registrant's Form 10-Q for the quarter ended June 30, 1999, and incorporated herein by reference). |
|
10.11 |
Integral Vision, Inc. 2004 Employee Stock Option Plan (filed as exhibit 10.11 to the registrants Form 10-Q for the quarter ended June 30, 2004 and incorporated herein by reference). |
|
16 |
Letter regarding change in certifying accountant (filed as exhibit 16 to the registrants Form 10-K for the year ended December 31, 2002, SEC file 0-12728, and incorporated herein by reference). |
|
27
31.1 |
Certification of Chief Executive Officer of Periodic Report pursuant to Rule 13a-15(e) or Rule 15d-15(e). |
|
31.2 |
Certification of Chief Financial Officer of Periodic Report pursuant to Rule 13a-15(e) or Rule 15d-15(e). |
|
32.1 |
Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350. |
|
32.2 |
Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350. |
|
28
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized.
INTEGRAL VISION, INC. | ||||
Dated: November 14, 2006 | By: | /s/ Charles J. Drake | ||
Charles J. Drake | ||||
Chairman of the Board and | ||||
Chief Executive Officer | ||||
Dated: November 14, 2006 | By: | /s/ Mark R. Doede | ||
Mark R. Doede | ||||
President, Chief Operating Officer | ||||
and Chief Financial Officer |
29